Anti-Inflammatory Role of TRPV4 in Human Macrophages

Yukiko Atsumi1,2, Manami Toriyama1,2,3, Hiroko Kato1,2

  • 1Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

Immunohorizons
|January 16, 2023
PubMed

Insights

Transient Receptor Potential Vanilloid 4 (TRPV4) activation suppresses inflammatory IL-1β production by inhibiting NF-κB signaling in macrophages. This suggests TRPV4 is a potential anti-inflammatory target for skin immune diseases.

Area of Science:

  • Immunology
  • Dermatology
  • Cell Biology

Background:

  • Skin immune diseases like atopic dermatitis involve macrophage overproduction of cytokines.
  • Mechanisms by which skin macrophages sense their environment are not fully understood.
  • Transient Receptor Potential Vanilloid 4 (TRPV4) channels regulate macrophage function but their role in skin immunity is unclear.

Purpose of the Study:

  • To investigate the role of TRPV4 in regulating macrophage function and its relevance to skin immune diseases.
  • To determine if TRPV4 activation affects inflammatory signaling pathways in human monocytes and macrophages.
  • To explore the potential of TRPV4 as an anti-inflammatory therapeutic target.

Main Methods:

  • Utilized human primary monocytes and derived macrophages.
  • Administered TRPV4 activators to assess effects on NF-κB signaling and cytokine production (IL-1β).
  • Examined macrophage differentiation into M1 and M2 subtypes.
  • Analyzed TRPV4 and inducible NO synthase expression in human skin biopsies from atopic dermatitis patients and healthy controls.

Main Results:

  • TRPV4 activation inhibited NF-κB signaling, leading to suppressed IL-1β production in human monocytes and macrophages.
  • TRPV4 activators reduced differentiation into M1 macrophages but not M2 macrophages.
  • Atopic dermatitis skin showed increased numbers of inducible NO synthase-positive/TRPV4-negative dermal macrophages compared to healthy skin.

Conclusions:

  • TRPV4 activation plays a role in suppressing inflammatory responses in macrophages.
  • TRPV4 may be involved in maintaining skin homeostasis.
  • TRPV4 represents a potential therapeutic target for treating inflammatory skin conditions like atopic dermatitis.